TB Treatment Follow-Up: Build a Reliable ATT Monitoring Record
An ATT follow-up record should show the current authorised TB regimen, when it changed, the patient's actual medicine use, dated clinical observations, investigation review and any adverse-effect concern. Keep dispensing, reported doses and clinician decisions separate. A weight entry or a completed medicine calendar must not automatically change treatment or imply that the regimen is effective or tolerated.
By Bractis · Updated · 9 min read
Indian private practitioners and clinic coordinators sharing TB treatment follow-up with NTEP services, hospitals and treating specialists.
Notification establishes a public-health reporting event; treatment monitoring follows the person through a changing course of care. A clinic can have a valid Nikshay identifier while still lacking the latest regimen or an important investigation. Start the visit by identifying who currently directs treatment and which dated source establishes the plan.
Record the actual medicines, formulations, instructions, start dates and authorised duration or review conditions. Distinguish a drug-susceptible treatment plan, a drug-resistant treatment plan and preventive treatment rather than using 'ATT' as if it names one interchangeable prescription. If resistance information or another clinical issue changes the plan, preserve the earlier version as history.
The NTEP treatment-card reference includes administered medicines, follow-up investigations, adherence, adverse events and outcomes. Those are linked but different domains. Its training description is useful for organising information; this article does not reproduce a dosing schedule from an older training module.
When a patient brings a hospital discharge sheet and a different medicine strip, record both sources and the discrepancy. Ask the responsible clinician or programme team to reconcile them. An assistant should not choose whichever regimen was entered most recently in the software.
Record weight with the measurement date, unit and relevant source. A measured weight today and a remembered weight from an earlier visit are not interchangeable. Where a prescribed regimen uses weight bands, show the clinician which measurement informed the current order; do not let crossing a software boundary silently alter the prescription.
Document the patient's account of actual use, including uncertain dates or interrupted treatment. A medicine-supply event demonstrates access to a quantity, not ingestion of every dose. A calendar marked by a caregiver is a reported history unless the observation method supports a stronger description.
Ask about interruptions in a way that identifies a solvable problem: medicine unavailable, travel, side effects, conflicting instructions or difficulty following the plan. Record the specific reason and the response. A single 'non-compliant' label obscures the difference between a supply failure and a clinical intolerance.
Do not assume an old additional medicine, including pyridoxine, remains appropriate merely because it appeared in the previous prescription. The responsible clinician should reconcile every current instruction. This guide intentionally supplies no automatic adjunct, dose adjustment or restart rule.
Build one timeline from several sources of evidence
A follow-up timeline should distinguish observation date, sample date, report availability and clinician review. A result arriving today may describe an earlier point in treatment. If these dates collapse into one 'last test' field, the next clinician may compare the wrong events or believe a pending result has been reviewed.
Retain the laboratory's original wording, units and qualifications. Link the clinician's interpretation and the action taken rather than replacing the report with a simple pass/fail label. The clinic should be able to identify which unresolved result still needs attention after the appointment has ended.
Keep an intended monitoring plan separate from completed observations. The exact investigations and frequency depend on the regimen, patient and responsible service. A universal monthly liver-test calendar would be an unsupported substitute for that plan.
Use the original evidence ledger below to clarify the distinction. It is a coordination aid, not a programme reporting form or a replacement for the authorised treatment record.
On a narrow screen, scroll the table horizontally to read all columns.
Original ATT monitoring ledger: what each event establishes
Event
Evidence to retain
Conclusion that needs separate support
Regimen authorised
Prescriber/service, date, medicines and effective start
That the patient obtained or took the medicines
Supply received
Product and quantity, date and source
That all supplied doses were used
Use reported
Patient/caregiver account and uncertain or missed dates
Directly observed ingestion
Monitoring result received
Patient, specimen date, units and original report
Clinical interpretation and decision
Concern assessed
Symptoms, timing, clinician review and action
A confirmed causal adverse drug reaction
Outcome recorded
Authorised assessment and supporting evidence
Completion inferred from elapsed calendar time
Make a new concern a clinical task with a clear owner
Ask the patient about new symptoms or difficulties and record when they began relative to treatment or a change. The report may require prompt clinical assessment even when the routine review is not due. Do not wait for a scheduled laboratory panel merely to make the visit record complete.
Record the suspected association without claiming causation prematurely. 'Patient reports nausea after taking the current medicines' is different from a confirmed adverse reaction to a named component. Preserve the clinician's assessment, any referral and the actual instruction given.
The Central Tuberculosis Division maintains anti-TB adverse-reaction resources, including patient information and professional materials. Use the current programme support and applicable regimen guidance for clinical decisions. A link to that resource index does not establish that the clinic has assessed the patient's concern or completed any required reporting.
Explain how to obtain timely help if a concerning symptom occurs between visits and how the patient can clarify a medicine instruction. Administrative staff should route the concern; they should not stop, restart or substitute individual TB medicines to resolve a calendar alert.
Transfer responsibility without losing the open questions
A patient may alternate between a local practitioner, district service and a referral hospital. A useful handover names the current treatment owner, latest authorised regimen, relevant investigation status, actual-use history and unresolved concern. A folder of prescriptions without a current summary leaves the receiving team to reconstruct the plan.
Confirm receipt of the handover through the agreed care process, while keeping acknowledgement distinct from clinical acceptance of responsibility. If the receiving service has not yet assessed the patient, record who remains responsible for the immediate question.
Support practical travel or supply coordination through the authorised programme route. A future appointment at another centre does not prove that the patient has enough correctly identified medicine or understands the transition. Record the arrangement and the remaining uncertainty.
The original summary below is designed to expose gaps. It should accompany, not replace, the actual prescription and programme documentation.
Use exceptions to evaluate the clinic's digital workflow
Test a fictional patient returning after travel with an outside regimen change and a partly used strip. Ask the operator to show what was prescribed, what was supplied and what the patient reports taking. The display should not turn those three histories into one row labelled 'adherent'.
Add a result that arrives after the consultation. The responsible clinician should be able to review it later with a new date and record whether the plan changes. A signed encounter should remain a truthful account of what was known at the time.
Then enter a new weight without changing the authorised prescription. The workflow should make a potential review question visible while preserving clinical control over treatment. A software demonstration that automatically rewrites medicine quantities is not evidence of a suitable monitoring process.
Audit a small defined sample for contradictory current regimens, unreviewed results and transfers with no owner. Describe those as process findings. A refill count, notification status or completed form cannot by itself measure microbiological response, treatment completion or patient safety.
Fictional example: supply looked complete but the treatment history was unclear
A patient returns from another district with enough medicine strips to cover the previous calendar period. The local record would otherwise mark every day complete. During reconciliation, the patient reports several missed days because of a concern and shows a later prescription from the receiving service. The clinician retains both regimen versions, records the actual-use account and contacts the treatment-owning team about the unresolved plan. No restart or dose adjustment is inferred from the strip count. The resulting timeline explains the discrepancy instead of hiding it behind a green calendar.
TB follow-up reconciliation
Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.
Current authority
Find the dated source that establishes the present regimen and identify the service responsible for resolving a conflicting prescription.
Exposure evidence
Separate one fictional supply event from reported and directly observed use. Preserve uncertain dates rather than filling every day.
Result ownership
Trace a specimen through report receipt, clinical interpretation and action. Name the owner of a result arriving after the appointment.
Transfer readiness
Prepare a concise handover of regimen, actual use, monitoring and open concerns, then identify what acknowledgement is still needed.
Questions doctors ask
Should a new weight automatically change an ATT prescription?
No. Record the measured weight and date and present any relevant issue to the responsible clinician. The current regimen and its dosing basis must be reviewed through the appropriate treatment process, not silently rewritten by a template.
Does collecting a month's medicines prove adherence?
It documents supply when the evidence is reliable. Actual use requires its own attributed account or observation. Preserve interruptions and their reasons; do not convert issued quantities into assumed doses taken.
Can every TB patient use the same laboratory monitoring schedule?
The plan needs to match the actual regimen, patient and treating service. Store its author, version and review instructions. A universal calendar should not replace regimen-specific clinical assessment.
Is this the same task as TB notification?
No. Notification and programme linkage are important events, but this guide concerns continuing treatment evidence and responsibility. A notified patient can still have an unresolved prescription, result or adverse-effect concern.
What matters most when treatment moves between clinics?
A verified current regimen, dated supporting records, actual-use history, relevant results and a named owner for unresolved questions. Keep previous versions and source attribution so the receiving team can understand what changed.
Sources and scope
Updated on . This is a treatment-record and coordination guide, not an ATT prescribing, interruption-management or adverse-reaction protocol. Regimen and monitoring decisions require the responsible clinician and current programme guidance. No independent clinical or legal review is claimed.
Indian NTEP training reference drawing on the 2020 medical-officer modules. Verified 25 October 2026 for treatment, follow-up, adherence and adverse-event recording domains; no current regimen is reproduced.
Official Indian index of anti-TB adverse-reaction resources. Indexed content checked 25 October 2026; the direct fetch timed out. Used to identify programme support, not to claim review of every linked protocol.
Connect diagnosis evidence, notification acknowledgement and ongoing TB care, reconcile existing Nikshay records and coordinate contacts without assuming submission completes treatment.
Use a fictional TB follow-up in Bractis with a new weight, an outside regimen change and a late result. Inspect whether the current authority and unfinished clinical tasks stay visible.